# FDA Inspection 974061 - ADMA Biologics, Inc - March 03, 2016

Source: https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/7cfce6d2-440b-4b1c-a3d4-96c2235b0b79
Source feed: FDA_Inspections

> FDA Inspection 974061 for ADMA Biologics, Inc on March 03, 2016. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 974061
- Company Name: ADMA Biologics, Inc
- Inspection Date: 2016-03-03
- Classification: Official Action Indicated (OAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1256275 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/81f31913-5145-4320-88eb-71fd5f3425fc)
- [FDA Inspection 1219342 - 2023-09-20](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/31541623-72bc-4c97-a8d8-f7d393a56f6c)
- [FDA Inspection 1150114 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/38c7c6b5-aeff-4b22-b122-2103db0e6d53)
- [FDA Inspection 1150114 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/9e2980ba-c12c-4572-a68c-4bdcd721419c)
- [FDA Inspection 1049629 - 2018-04-12](https://www.keypedia.com/records/fda_inspections/adma-biologics-inc/b5405d37-cfbd-4a12-aea8-1f51ffeecff0)

Company: https://www.keypedia.com/companies/adma-biologics-inc/dcb996fb-4a71-44fe-87f1-cfe3979d4182

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d